Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    19879702 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Gefitinib, Paclitaxel, and Radiation Therapy in Treating Patients With Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck
Condition: Head and Neck Cancer
Interventions: Drug: gefitinib;   Drug: paclitaxel;   Radiation: radiation therapy

Indicates status has not been verified in more than two years